Jeffrey Chodakewitz, EVP GMDA, CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,390 shares at $152.50 ($831K) on 2017-08-02, disclosed to the SEC on 2017-08-04.
Open-market sale of $831k VRTX by EVP GMDA, CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.50 | 500 | $76K | 9.2% |
| 2 | $153.93 | 600 | $92K | 11.1% |
| 3 | $154.89 | 400 | $62K | 7.5% |
| 4 | $156.24 | 296 | $46K | 5.6% |
| 5 | $153.29 | 600 | $92K | 11.1% |
| 6 | $154.21 | 2,494 |
| $385K |
| 46.3% |
| 7 | $155.15 | 500 | $78K | 9.3% |
| Total | $154.17 avg | 5,390 | $831K | 100% |
| Filing → |
| VRTX | SELL | 2018-02-05 | $782K | — | Filing → |
| VRTX | SELL | 2018-01-17 | $351K | — | Filing → |
| VRTX | SELL | 2018-01-03 | $756K | — | Filing → |